(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics
 
 
Alternative Scenarios - 3
Blood Banking - 105
Cancer - 92
Clinical Chemistry - 262
Coagulation - 89
Decentralized Testing - 3
DNA Probes/Biochips - 33
Genetic Testing - 1
Hematology/Flow Cytometry - 98
Hemostasis - 70
Histology/Cytology - 2
Immunodiagnostics - 26
Infectious Diseases - 295
Microbiology Testing - 80
Molecular Diagnostics - 141
NAT - 82
POC Testing - 163
Strategic Planning - 24
Top 10 Companies - 22
Transfusion Testing - 84
Tumor Markers - 75
 
 In Vitro Diagnostics Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  30  31  32  33  34  35  36  37  38  39  Next »
2022 German Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers

Highlights

  • Comprehensive 585-page analysis of the German tumor marker testing market.
  • Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years....

 

$3500.00
       
2022 Japanese Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers

Highlights

  • Comprehensive analysis of the Japanese tumor marker testing market.
  • Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years....

 

$3500.00
       
2022 Italian Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers

Highlights

  • Comprehensive 570-page analysis of the Italian tumor marker testing market.
  • Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years....

 

$3500.00
       
2022 Spanish Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers

Highlights

  • Comprehensive 565-page analysis of the Spanish tumor marker testing market.
  • Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years....

 

$3500.00
       
2022 UK Tumor Marker Testing Market Innovations, Trends and Opportunities for Suppliers

strong>

Highlights

  • Comprehensive 575-page analysis of the UK tumor marker testing market.
  • Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years....

 

$3500.00
       
Emerging Strategies for the Global Tumor Marker Testing Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.

The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.



 

$3500.00
       
Tumor Markers: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.

The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.



 

$3500.00
       
2023 Analysis of the Point-of-Care Infectious Disease Diagnostics Market: US, Germany, Spain
Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers


This new report from Venture Planning Group provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market.



 

$3500.00
       
2023 Analysis of the Point-of-Care Hematology and Flow Cytometry Markets: US, Germany, Spain
Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs,
Cancer Clinics, Ambulatory Care Centers, Surgery Centers,
Nursing Homes, Birth Centers


This new report from Venture Planning Group provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market.

 

$3500.00
       
2023 Analysis of the Point-of-Care Clinical Chemistry Market:
US, Germany, Spain
Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs,
Cancer Clinics, Ambulatory Care Centers, Surgery Centers,
Nursing Homes, Birth Centers


This new report from Venture Planning Group provides a comprehensive analysis of the POC clinical chemistry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC clinical chemistry market.

 

$3500.00
       
2023 New Frontiers in Point-of-Care/POC Coagulation Testing: Business Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Point-of-Care/POC Coagulation Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of the POC coagulation testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

 

$3500.00
       
2023 POC Molecular Infectious Disease Testing Market: Supplier Shares, Test Volume & Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review-Physician Offices, Emergency Rooms, Ambulatory Care Centers

New Frontiers in Point-of-Care/POC Infectious Disease Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of the POC infections disease testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

 

$3500.00
       
Analysis of the World Transfusion Diagnostic Testing Market:
Sales Forecasts by Country and Strategic Profiles of Leading Suppliers


This report provides a worldwide overview of the Transfusion Diagnostic Testing market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country.

The report also presents analyses of leading current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.



 

$3500.00
       
2023 Analysis of Transfusion Diagnostic Typing, Grouping and Screening Tests, And Strategic Profiles and Leading Suppliers

This report presents a comprehensive analysis of the clinical significance and market needs for major transfusion diagnostic typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing innovative blood banking technologies and products.



 

$3500.00
       
Analysis of Transfusion Diagnostic Instrumentation
And Strategic Profiles of Leading Suppliers


This report reviews current instrumentation technologies, and compares features of leading transfusion diagnostic automated and semi-automated analyzers.



 

$3500.00
       
2023 Analysis of Blood Typing, Grouping and Screening Tests,
and Strategic Profiles of Leading Suppliers


This new report from Venture Planning Group presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing innovative blood banking technologies and products.

The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 225 pages and 6 tables



 

$3500.00
       
2023 Analysis of Transfusion Diagnostic Instrumentation
and Strategic Profiles of Leading Suppliers


This new report from Venture Planning Group reviews current instrumentation technologies, and compares features of leading transfusion diagnostic automated and semi-automated analyzers.

The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.



 

$3500.00
       
2015 Analysis of Transfusion Diagnostic Technologies, and Strategic Profiles of Leading Suppliers

This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for transfusion diagnostic.



 

$3500.00
       
« Previous     30  31  32  33  34  35  36  37  38  39   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X